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Abstract: Proteins involved in membrane remodeling
play an essential role in a plethora of cell functions
including endocytosis and intracellular transport. Defects
in several of them lead to human diseases. Myotubularins,
amphiphysins, and dynamins are all proteins implicated in
membrane trafficking and/or remodeling. Mutations in
myotubularin, amphiphysin 2 (BIN1), and dynamin 2 lead
to different forms of centronuclear myopathy, while
mutations in myotubularin-related proteins cause Char-
cot-Marie-Tooth neuropathies. In addition to centronuc-
lear myopathy, dynamin 2 is also mutated in a dominant
form of Charcot-Marie-Tooth neuropathy. While several
proteins from these different families are implicated in
similar diseases, mutations in close homologues or in the
same protein in the case of dynamin 2 lead to diseases
affecting different tissues. This suggests (1) a common
molecular pathway underlying these different neuromus-
cular diseases, and (2) tissue-specific regulation of these
proteins. This review discusses the pathophysiology of the
related neuromuscular diseases on the basis of animal
models developed for proteins of the myotubularin,
amphiphysin, and dynamin families. A better understand-
ing of the common mechanisms between these neuro-
muscular disorders will lead to more specific health care
and therapeutic approaches.
Introduction
Membrane remodeling occurs in diverse and essential cellular
processes, including endocytosis, intracellular transport, and
synaptic vesicle fusion. There are numerous proteins related to
membrane remodeling that have diverse functions, including
regulation of lipids, membrane adaptor proteins, or cytoskeletal
organization. Several genes implicated in membrane remodeling
and trafficking are mutated in different forms of human
neuropathies (DNM2, MTMR2, MTMR13, NEFL, RAB7A,
FGD4, FIG4, SH3TC2, LITAF/SIMPLE) and myopathies
(MTM1, BIN1, DNM2, CAV3, DYSF) (reviewed in [1]).
The purpose of this review is to discuss how several protein
families with functions in membrane remodeling act in the same
pathway and how defects of several of these proteins can induce
similar human diseases. We consider here animal models of the
myotubularin/amphiphysin/dynamin pathway, highlighted by
their common implication in both centronuclear myopathies
(CNM) and peripheral Charcot-Marie-Tooth neuropathies
(CMT). Myotubularins are phosphoinositides phosphatases, am-
phiphysins are BAR (BIN1, Amphiphysin and RVS167) proteins
sensing membrane curvature and regulating membrane remodel-
ing, and dynamins are large GTPases able to tubulate and
eventually cleave membranes. Members of these protein families
are commonly mutated in several neuromuscular diseases affecting
different tissues, suggesting a common pathological pathway and
tissue-specific regulations. As other neuromuscular disease genes
encode for proteins implicated in membrane transport, this
proposed pathological pathway may link together a larger number
of membrane trafficking proteins.
The Myotubularin Family
Myotubularin proteins are mutated in two human diseases,
centronuclear myopathy (XLCNM, OMIM 310400) and CMT
neuropathy. MTM1 is mutated in the X-linked, most severe form
of CNM [2,3]. Boys with MTM1 mutations causing X-linked
CNM present a very severe and generalized muscle weakness at
birth (Figure 1). Death normally occurs within the first year of life
due to respiratory failure. Centralized nuclei in hypotrophic fibers
are a prominent feature in muscle [2,3].
CMT comprises a genetically heterogeneous group of inherited
disorders affecting myelinated axons in the peripheral nervous
system. The disease is characterized by progressive distally
accentuated muscle weakness and atrophy. CMT has been
subdivided into demyelinating, axonal and intermediate forms
on the basis of clinical, electrophysiological, and histological data.
CMT4B are severe demyelinating autosomal recessive inherited
neuropathies. They are divided in two subgroups (Figure 1; Table
S1), CMT4B1 (MTMR2 mutations, OMIM 601382) and
CMT4B2 (MTMR13 mutations, OMIM 604563) [4–7].
Myotubularin (MTM1) is the founding member of a large
family of phosphoinositide phosphatases (Figure 1). Myotubularins
are 3-phosphatases that play an essential role in maintenance of
the spatial and temporal equilibrium of phosphoinositides (PIs),
molecular membrane flags that have key roles in membrane
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PLoS Genetics | www.plosgenetics.org 1 April 2012 | Volume 8 | Issue 4 | e1002595Figure 1. Protein domains and disease-causing mutations in the myotubularin, amphiphysin, and dynamin families. Myotubularin
contains a PH-GRAM domain that may bind lipids and a coil-coiled-PDZ binding site to form homo- and hetero-dimers with other members of the
myotubularin family. Only the disease-causing missense mutations in MTM1 are represented, based on the international UMD-MTM1 database,
PLoS Genetics | www.plosgenetics.org 2 April 2012 | Volume 8 | Issue 4 | e1002595identity and protein recruitment [8,9]. Via its tyrosine phospha-
tase-like (PTP) domain, MTM1 dephosphorylates phosphatidyli-
nositol 3-phosphate (PtdIns3P) and PtdIns(3,5)P2, second messen-
gers produced by PI 3-kinase (PI3K) and 5-kinase (PI5K)
respectively, with important roles in endocytosis and membrane
trafficking [10].
In mammals, the myotubularin family is composed of MTM1
and 13 MTM1-related (MTMR) proteins named MTMR1 to
MTMR13 [11,12] (Figure 2). All contain PTP-like and PH-
GRAM domains. Six MTM family members contain an inactive
catalytic site owing to conserved substitutions of several amino
acids essential for activity [11,13,14]. These dead phosphatases,
MTMR5 and MTMR9–13, heterodimerize with active myotubu-
larins to regulate their phosphatase activity [12]. To date five pairs
of active-dead phosphatases have been confirmed, MTM1-
MTMR12, MTMR2-MTMR5, MTMR2-MTMR13, MTMR7-
MTMR9, and MTMR6-MTMR9 [15–19]. Interestingly muta-
tions in the coupled active and dead phosphatases, MTMR2 and
MTMR13, lead to very similar neuropathies, distinguished only by
the age of onset and the major involvement of proximal muscles in
CMT4B1, often resulting in a more severe neuropathy.
Myotubularin Drosophila Model
How the balance between specific kinases and phosphatases that
regulate PI levels, and how disruption of this coregulation may
lead to neuromuscular diseases remains unresolved. Studies using
Drosophila have shown that Drosophila myotubularin (mtm, the
ortholog of human MTM1 and MTMR2) coordinates with class II
PI3K to modulate levels of PtdIns3P within the cell, which is
important in regulating endolysosomal functions and cortical actin
remodeling [20], and plays a role in integrin-mediated attachment
of myofibers [21]. Integrin accumulated with PtdIns3P on
endosomal vesicles when mtm was depleted, and integrin
localization defects have also been observed in CNM patients
[21]. This suggests that mtm/PI3K regulation may coordinate
integrin trafficking and recycling to the plasma membrane.
Modulating class II PI3K levels may therefore constitute a
potential therapeutic target for CNM.
Myotubularin Caenorhabditis elegans Model
In C. elegans, six myotubularins have been identified, including
three active phosphatases MTM-1, MTM-3, and MTM-6, and
three dead phosphatases, MTM-5, MTM-9, and MTM-10 [11,22–
24], suggesting that the cooperation between active/dead phospha-
tases is conserved through evolution [17,25,26]. Specifically the
MTM-6/MTM-9 complex regulated endosomal trafficking of the
Wnt signaling complex [27]. However all myotubularins appear to
be required for the endocytosis of fluid in coelomocytes from the
pseudocoelome, a process called coelomocyte uptake (Table S1)
[24,26,28]. Both mtm-1 and mtm-6 play a role in coelomocytes
endocytosis, most likely by antagonizing Let-512 function (a PI3K in
C. elegans, and a Vps34 homolog) [24]. A balance between mtm-1 and
Vps-34 also regulates cell corpse engulfment of apoptotic cells, as
MTM-1 inhibited this process via its phosphatase activity [28,29].
In both mechanisms,MTM-1regulationofPtdIns3P levelscould be
essential for membrane remodeling. Human MTM1 can substitute
the worm MTM-1 function in cell corpse engulfment suggesting
that MTM1, or its closer homologue MTMR2, can act similarly in
human peripheral nerve or skeletal muscle, two tissues in which
defects in MTM1 or MTMR2 induce diseases.
Myotubularin-Defective Animal Models for Muscle
Pathologies
mtm-1 zebrafish morphants. Dowling et al. have
generated a zebrafish model for X-linked CNM by morpholino
knockdown of zebrafish MTM1 [30], which exhibited a delayed
chorion hatching and a diminished touch-evoked escape behavior.
Abnormally located nuclei, hypotrophy and organelle disruption,
and neuromuscular junction disorganization were observed, as
seen in patient muscle biopsies [30,31]. The role of MTM1 as the
primary PtdIns3P phosphatase in skeletal muscle development was
reinforced by an increase of PtdIns3P level observed in the skeletal
muscle of myotubularin morphants, but not in whole embryos.
The rescue of the early muscle weakness by MTMR1 and
MTMR2, the closest MTM1 paralogs, suggested that the specific
muscle defect induced by a loss of MTM1 is due to the lack of
compensation by other PtdIns3P myotubularin phosphatases in
muscle [30]. Reduction of myotubularin in skeletal muscle affected
the organization and the morphology of the T-tubules and
sarcoplasmic reticulum (SR) and suggested that the regulation of
PtdIns3P and PtdIns(3,5)P2, is essential for the excitation-
contraction coupling machinery (Table S1). Indeed, impairment
of MTMR14/JUMPY, a phosphatase sharing similar enzymatic
activity to MTM1, led to T-tubule anomalies and PtdIns(3,5)P2
dependent defect of excitation-contraction coupling in mouse
skeletal muscles [32,33].
MTM1 mammalian models. The murine model of X-
linked CNM generated by targeted mutagenesis of MTM1 [34]
exhibited a progressive motor deficit and amyotrophy. Contrary to
patients who display a strong muscle weakness from birth,
knockout (KO) muscles appeared normal up to 2 wk of age.
Mice then exhibited a progressive decrease in muscular strength
with similar histopathology to patients [34,35]. Death occurred
around 7–12 wk probably because of cachexia and respiratory
insufficiency. Tissue-specific excision of Mtm1 exon 4 confirmed
that the muscle phenotype is due to loss of MTM1 function in
skeletal muscle and not in nerves [34]. Altogether, this suggests
that MTM1 is not essential for myogenesis but is important for
muscle structural maintenance (Table 1). As in zebrafish
myotubularin morphants, the loss of myotubularin in mouse
skeletal muscle induced abnormal organization of the triads and
T-tubules, which appeared prior to defects in excitation-
contraction coupling [30,35]. Similar triad defects have been
noted in patients with mutations in MTM1 [36] and in Labrador
retrievers with a mutation in MTM1, the latter providing a large
animal model in which therapeutic trials could be envisaged [37].
MTM1 was shown to directly bind and regulate desmin
localization, and MTM1 mutations causing CNM result in
abnormal intermediate filament assembly and architecture, and
perturbed mitrochondrial dynamics [38]. Re-expression of Mtm1
existing currently in a local version in Strasbourg (France). MTM1 mutations identified in more than two patients are R69C(9 families), P205L(5),
V227M(3), R241C(13), G378R(4), E404K(4), and Y397C(5). AMPH1 and BIN1 possess an N-BAR domain able to sense and eventually curve membrane
and a C-terminal SH3 domain binding to proteins with proline-rich domains, such as dynamins [48,88]. In addition some isoforms have clathrin-
binding and Myc-binding domains (CBD, MBD); a phosphoinositide-binding motif is present between the BAR and MBD domains specifically in
skeletal muscle. DNM2 contains a GTPase domain, a central middle (MID) domain, a Pleckstrin Homology (PH) domain, a GTPase Effector Domain
(GED), and a C-terminal Proline Rich Domain (PRD). Dominant mutations in DNM2 lead to either centronuclear myopathy (above), or peripheral CMT
neuropathy (below). Only coding mutations are listed for all genes.
doi:10.1371/journal.pgen.1002595.g001
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in Mtm1 knockout mice and rescued desmin aggregation [38,39].
Altogether, myotubularin might specifically regulate the
appropriate organization and/or maintenance of triads through
fine regulation of specific PI pools at the plasma and reticulum
membranes, in skeletal muscle. These results provided new insight
into the mechanisms causing CNM and indicated a com-
mon pathological link between CNM and desmin-related
myopathies.
Myotubularin-Related Animal Models for Neuropathies
MTMR2 and MTMR13 murine models. Mtmr2-deficient
mice start developing peripheral nerve abnormalities at 1 mo of
age (Table 1) [40–42]. They present a dysmyelinating phenotype
similar to CMT4B1 patients, consisting of motor and peripheral
neuropathy with myelin outfoldings and redundant loops
appearing as membrane extensions originating predominantly
from paranodes, a region in between compact myelin and nodes of
Ranvier. Expression of the MTMR2 binding protein Dlg-1/
SAP97, a scaffolding protein belonging to the MAGUK protein
family, decreased in Mtmr2-null mice, suggesting that loss of
interaction between MTMR2 and Dlg-1/SAP97 disrupts cell
polarity and cellular junctions or membrane remodeling in
Schwann cells, leading to membrane outfoldings at paranodes.
Two Mtmr13-deficient mouse models have been generated, both of
which led to a loss of MTMR13 expression and reproduced the
CMT4B2 phenotype, including myelin outfoldings and infoldings
(Table 1) [43,44]. As in Mtmr2-deficient mice, myelin outfoldings
were found near nodes of Ranvier and increased in number and
complexity with age [43,44]. Double Mtmr2/Mtmr13-deficient
mice presented no additional or more severe phenotype,
suggesting MTMR13 regulates MTMR2 [43] and is consistent
with data showing a strong increase of MTMR2 phosphatase
activity when MTMR2 and MTMR13 formed a complex [19,45].
Figure 2. Phylogenetic relationships. Phylogenetic relationships within the amphiphysin (A), dynamin (B), and myotubularin (C) protein families.
Sequences were collected using the eggNOG database, which groups genes into families at different taxonomic levels. A high quality multiple
sequence alignment was computed for each protein family on all proteins members including, respectively, 91 myotubularin protein sequences, 23
dynamin protein sequences, and 13 amphiphysin protein sequences. For a more detailed description, see Protocol S1. Scale represents the
percentage of divergence.
doi:10.1371/journal.pgen.1002595.g002
Table 1. Myotubularin/amphiphysin/dynamin protein functions in specific tissues, based on animal and cell models.
Gene Mouse Model(s) Specific Muscle Function(s) Specific Nervous System Function(s) Reference(s)
Mtm1 KO (CMV-Cre) is postnatally lethal week 6–14,
most likely due to cachexia and respiratory
insufficiency
Essential for muscle maintenance;
organization and morphology of
T-tubules/sarcoplasmic reticulum
(SR)/mitochondria; nuclei position
and fiber type expression; integrin
localization and PIs important for
muscle cells attachment
[21,30,34,35]
Muscle KO (HSA-Cre) similar viability to total KO
Neuronal KO (NSE-Cre) viable and no obvious
symptoms (up to 14 wk)
Mtmr2 KO mice survive $15 mo of age, progressive
CMT4B1-like neuropathy
Myelin sheath maintenance [6,41,42,89]
Schwann cell KO mice survive $15 mo;
dysmyelinating phenotype similar to total KO
Motor neuron KO mice survive $12 mo, no
dysmyelination or axonopathy observed
Mtmr13 KO mice indistinguishable to wildtype until
$15 mo of age, exhibit progressive CMT4B2-
like neuropathy
Myelin sheath maintenance [19,43]
Amph1 Premature death due to spontaneous seizures;
5 0 %s u r v i v et o1 0m oo l d
Synaptic vesicles recycling in brain [56]
Bin1 KO is perinatally lethal (often within 24 h of
birth), exhibit cardiac structural defects
Membrane remodeling at T-tubules? [55]
Dnm1 KO is postnatally lethal, within 2 wk of birth,
probably due to synaptic vesicle endocytosis
defects
Essential role in neurotransmission
and synaptic vesicle endocytosis
during intense stimulation
[73,77,79]
Dnm2 KO is embryonically lethal (prior to embryonic
day 10)
Important for muscle maintenance;
maintenance of T-tubule, reticulum,
and mitochondrial network
[67,80–82]
R465W HMZ KI is perinatally lethal within 24 h
of birth, may be due to clathrin-mediated
endocytosis defects
R465W HTZ KI mice are viable with no reduced
lifespan, myopathic phenotype
doi:10.1371/journal.pgen.1002595.t001
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The autosomal recessive form of CNM (ARCNM, OMIM
255200) normally presents with muscle weakness typically
appearing in infancy or early childhood, although cases were
reported to present strong hypotonia at birth [46,47]. The
mutated gene associated with some cases of ARCNM is BIN1,
encoding amphiphysin 2 (Figure 1) [46]. Amphiphysins belong to
the BAR protein family [48]. They play roles in membrane
remodeling and are conserved between humans and Drosophila,
with functional orthologs found in yeast. In mammals, two genes
encode for amphiphysins; amphiphysin1 (Amph1) and amphiphy-
sin2 (BIN1) (Figure 2). Amph1 is expressed in brain and is
implicated in synaptic endocytosis. BIN1, initially described as a
tumor suppressor via its c-myc binding domain, is ubiquitously
expressed although different isoforms are formed by complex
alternative splicing that appears tissue specific [36,49]. The
muscle-specific isoform of BIN1 (iso8) contains a phosphoinosi-
tides-binding domain, and plays a role in T-tubule biogenesis
[50,51]. Nevertheless, mutations leading to CNM are found in
common domains of the numerous BIN1 isoforms. Auto-
antibodies against AMPH1 lead to a rare auto-immune disease
called Stiff-man syndrome, involving chronic muscle rigidity and
episodic spasms, sometimes with a paraneoplastic origin [52].
Amphiphysin Drosophila Model
The fly model has been generated by disruption of the only gene
encoding amphiphysin (Amph)i nDrosophila [53]. Adult Amph-
deficient flies displayed no synaptic vesicle defects but were
flightless and sluggish. Loss of Amph resulted in severe disorgani-
zation and reduction of the T-tubules, similar to the triads defect
observed in CNM patients with BIN1 mutations [36] and in
Mtm1-deficient mice and mtm1-deficient Zebrafish, reinforcing the
hypothesis that MTM1 and amphiphysin 2 work in the same
pathway in skeletal muscle.
Amphiphysin C. elegans Model
AMPH-1 is the only amphiphysin in C. elegans. AMPH-1 directly
interacts and colocalizes with the membrane tubulating ATPase
RME-1 (EHD ortholog) on membrane tubules from recycling
endosomes [54]. Similarly to RME-1 mutants, loss of AMPH-1
induced a defect in basolateral recycling in the polarized intestinal
epithelium. AMPH-1 may function in part to recruit RME to
membrane of recycling endosomes [54]. All together these data
suggest that AMPH-1 is implicated in recycling, probably through
membrane remodeling and RME-1 recruitment (Table S1).
Amphiphysin 2/BIN1 Mouse Models
Deletion of the exon 3 in Bin1 led to loss of protein in
homozygous mice [55]. Bin1-null embryos developed normally but
died perinatally, potentially because of occlusion of the ventricular
chambers. Unexpectedly there was no demonstrable impact of
BIN1 loss on apoptosis, actin cytoskeletal organization, endocy-
tosis, or on the specialized phagocytic endocytosis. Cardiac
myofibrils were loosely packed and disorganized, with defective
sarcomere units, diffuse Z-lines, and no apparent A-bands. Skeletal
muscle was not thoroughly analyzed [55]. Moreover, as in
Drosophila, Bin1-deficient mice presented normal brain architecture
and synaptic vesicles, reinforcing the non-essential function of
BIN1 in brain.
Amphiphysin 1 Murine Model
Amph1-deficient mice have been created by deletion of exon 1
(Table 1) [56]. AMPH1 and BIN1 form heterodimers in the brain,
and absence of AMPH1 resulted in a strong reduction in BIN1
level in brain but not skeletal muscle [56]. Conversely, the
expression level of Amph1 was not altered in the brain of Bin1-
deficient mice, suggesting that Bin1 is not essential for Amph1
stability and function in brain [55]. Amph1-deficient mice suffered
severe uncontrollable seizures, leading to reduced viability with
50% of mice dying by 40 wk of age. A reduction in synaptic vesicle
recycling efficiency and reduced recruitment of AP-2 (alpha
adaptin) and clathrin to membranes were detected [56]. AMPH1
is localized to the tubulobulbar complex (TBC) in Sertoli cells, and
absence of AMPH1 led to a reduced number of plasma membrane
invaginations and a subsequent increase number of unreleased
spermatids [57].
According to the different animal models generated for
amphiphysins and other cell studies, AMPH1 and BIN1 appear
to have specialized functions depending on their splice isoforms
and tissues where they are expressed. AMPH1 and brain isoforms
of BIN1 might be dedicated to endocytosis and/or recycling,
and non-neuronal AMPH1 and BIN1 proteins play a major
role in plasma membrane remodeling and trafficking (Tables 1
and S1).
The Dynamin Family
Although ubiquitous expression and the central role of DNM2
in endocytosis suggested an essential function in all tissues, DNM2
was found mutated in two tissue-specific human diseases:
autosomal dominant centronuclear myopathy (ADCNM, OMIM
160150) and dominant intermediate Charcot-Marie-Tooth neu-
ropathy (DI-CMTB, OMIM 606482) (Figure 1) [58,59]. The
autosomal dominant form of CNM is generally clinically mild and
usually appears in adults with a diffuse weakness that is slowly
progressive and may be accompanied by muscle hypertrophy.
However the severity varies from mild late-onset to severe
neonatal onset [58,60–63]. DNM2 mutations are also linked to
either DI-CMTB with intermediate conduction velocity and
associated neutropenia or axonal CMT. How different mutations
in the same gene cause two diseases affecting different tissues
(peripheral nerve and muscles) remains unexplained.
Dynamins belong to a large family of GTPases involved in
formation and fission of budding vesicles from the plasma
membrane and Golgi [64,65]. In humans, the dynamin family
comprises DNM1, DNM2, and DNM3 (Figure 2). DNM2 is
ubiquitously expressed, DNM1 is present mainly in brain, and
DNM3 is detected in brain and testis. Specific isoforms of each
dynamin have been linked to specific subcellular localization and
functions [66,67]. Via the Pleckstrin homology (PH) and proline
rich domains (PRD) domains, DNM2 binds respectively to the
phosphoinositides PtdIns(4,5)P2, and to Src-Homology-3 (SH3)
domain proteins including amphiphysins.
Drosophila Dynamin Models
In Drosophila the shibire (shi) gene encodes for the ortholog of
mammalian dynamins. At non-permissive temperatures, the shi
ts1
and shi
ts2 mutations prevent GTP hydrolysis and shibire flies display
disrupted synaptic vesicle endocytosis and depleted synaptic
terminal vesicles [68–70]. Synaptic vesicles were trapped at a
‘‘collared-pit’’ stage in membrane internalization, and inactivation
of the GTPase domain abolished vesicle translocation [70].
Dynamin regulates endocytosis in a variety of tissues [69,71]. In
cardiac tissue, recessive shi
ts1 and shi
ts2 mutations exhibited
bradychardia and arrhythmia because of defects in electrical
communication throughout the myocardium [72].
PLoS Genetics | www.plosgenetics.org 6 April 2012 | Volume 8 | Issue 4 | e1002595Dynamin C. elegans Models
Dyn-1 is the unique dynamin expressed in C. elegans. Dyn-1(ky51)
mutant worms had uncoordinated movement, kinked posture, and
were sluggish at non-permissive temperatures [73]. This is
consistent with the enrichment of Dyn-1 in motor neurons that
innervate bodywall muscles and head musculature, required
respectively for locomotion and head movement [73]. Dyn-1
concentration in the nerve ring indicated a role in synaptic vesicle
recycling [74]. In non-neuronal cells, Dyn-1 defects in coelomo-
cytes led to decreased fluid-phase endocytosis. Dyn-1 (n4039)
worms revealed that dynamin also has a role in engulfment and
degradation of apoptotic cells during embryogenesis [75].
Interestingly, human DNM2 could perform a similar function to
Dyn-1 in C. elegans [75]. These results suggest that dynamin
proteins can have similar functions when expressed in the same
tissue. In gonadal sheath cells, absence of Dyn-1 led to
accumulation of enlarged vesicles, vesicles interconnected via lipid
tubules, and plasma membrane-connected vesicles, all suggesting
defects in fission [75]. A role for Dyn-1 in membrane transport has
also been characterized for the maintenance of anterior polarity in
C. elegans embryos (Table S1) [76].
Dynamin 1 Mammalian Models
Dnm1-deficient mice were indistinguishable from littermates at
birth, however decreased ingestion of milk and poor motor
coordination were detected, and mice usually died within 2 wk
[77]. Analyses of the structure and function of synapses from
Dnm1-deficient mice highlighted that DNM1 was dispensable for
endocytic recycling of synaptic vesicles under basal conditions but
became essential when intense stimulus imposed a heavy load of
endocytosis [77]. Expression of DNM2 or DNM3 rescued partially
or efficiently, respectively, the endocytic blockade in DNM1-
defective cultured neurons, indicating that all dynamins could
participate in synaptic vesicle endocytosis. This was recently
confirmed in DNM1/DNM3 double KO [78].
An homozygous Arg256Leu DNM1 mutation was identified in
Labrador retrievers affected with exercise-induced collapse [79]. A
collapse episode lasts 5–10 min and complete recovery usually
occurs after 30 min. Arg256Leu affects an amino acid conserved
in DNM2 and DNM3, which is located at the boundary between
the GTPase and the MID domains [79]. Similar to Drosophila and
C. elegans temperature-sensitive phenotypes, the mutation in canine
DNM1 may lead to a defect in synaptic vesicle recycling that
sustains synaptic transmission during intensive exercise (Table S1).
Dynamin 2 Murine Models
Dnm2 KO mice died before embryonic day 10 [80]. In double
Dnm1/Dnm2 null fibroblasts, clathrin-mediated endocytosis is
arrested and endocytotic intermediates accumulated in the
cytoplasm [80]. Heterozygous R465W-DNM2 knock-in mice,
the most common mutation causing ADCNM, exhibited a fairly
mild myopathic phenotype, with abnormalities in mitochondrial
and reticular networks [81]. However homozygous mice died
hours after birth, possibly owing to clathrin-mediated signaling
defects, correlating with the above results from Dnm1/Dnm2 KO
cells. A second model was created by intramuscular adeno-
associated virus (AAV) injections of R465W-DNM2 into adult
wild-type muscle. Mice exhibited muscle weakness associated with
disruptions of the mitochondrial and T-tubule networks [82]. This
model reproduced most ADCNM features in mice, and was akin
to ADCNM patient biopsies [36]. These models provide evidence
that ADCNM arises primarily from defects in skeletal muscle
rather than peripheral nerves, and that dynamin 2 is crucial in the
maintenance of adult muscle fiber structure and function.
A Common Molecular Mechanism?
Myotubularins are phosphatases regulating the level of PIs,
amphiphysins can bend membranes, and dynamins oligomerize
around the neck of vesicles to promote tubulation and eventually
membrane fission. All these proteins fit in a membrane remodeling
pathway (Figure 3) and are associated with myopathies and
peripheral neuropathies or neurological syndromes. It is not yet
clear if mutations causing more severely defective proteins
correlate with earlier onset, or more severe forms of the disease,
nor is it clear if the location of mutations within genes gives rise to
tissue-specific disorders. A more detailed analysis of the impact of
mutations on the protein functions is needed to answer these
points. The above pathological pathway may also be expanded to
include other genes mutated in CMT and other myopathies. This
could include several genes mutated in different forms of CMT
(e.g., NEFL, RAB7A, FGD4, FIG4, SH3TC2, LITAF/SIMPLE)
(reviewed in [83]) encoding proteins regulating PIs metabolism
and membrane trafficking; and myopathies involving mutations in
caveolin 3 and dysferlin genes, which also lead to common defects
in T-tubules and membrane transport in patients and animal
models (Figure 3) [84,85]. While mutations in several membrane
trafficking proteins described here are associated with neuromus-
cular disorders, in contrast mutations affecting normal lysosomal
function induce a separate category of human diseases termed
lysosomal storage diseases (LSD), which affect several tissues, most
commonly causing progressive neurodegeneration. We propose a
hypothesis to explain how different protein families are implicated
in similar diseases while, conversely, the same protein families are
associated with different neuromuscular diseases (Figure 3;
Table 1).
Neurological Functions
These proteins could coordinate vesicle formation and endocy-
tosis and recycling. Schwann cells require large amounts of plasma
membrane to wrap around axons and may be more susceptible
than other cell types to membrane transport defects. This pathway
is also important at the synapse that requires very rapid trafficking
and recycling through membrane fission, transport, and fusion.
Amphiphysins and dynamins are well-known interactors and
regulators of endocytosis, and dynamins are excellent candidates
for membrane fission. Indeed dynamin inhibition leads to
decreased separation of vesicles from the plasma membrane
[70]. Several myotubularins have been implicated in endocytosis,
through regulation of PtdIns3P and PtdIns(3,5)P2 levels in
Drosophila, C. elegans, zebrafish, and mice models, and these PIs
were shown to be key players in both endocytosis and exocytosis
[8,9]. Such membrane trafficking is implicated in synaptic vesicle
recycling in brain, and in recycling of adhesion molecules that may
be important for cell–cell contact and myelin sheath formation or
maintenance. Defects in these pathways could explain the
hallmarks of neurological syndromes and neuropathies associated
with mutations in these protein families.
Skeletal Muscle Functions
In skeletal muscle, MTM1, BIN1, and DNM2 may coordinate
the formation and/or organization of T-tubule/triad structures
(Figure 3). Following induction of membrane curvature, the
invagination may become elongated to form a T-tubule. BIN1 is
highly expressed in skeletal muscle and was implicated in T-tubule
biogenesis in Drosophila and muscle cells [51,53], and T-tubule
defects are seen in zebrafish and mouse animal models, and in
CNM patients with mutations in these three proteins [36]. BIN1
contains a phosphoinositide-binding domain present only in the
PLoS Genetics | www.plosgenetics.org 7 April 2012 | Volume 8 | Issue 4 | e1002595muscle isoform indicating PIs are involved in this process, however
their role and the function of MTM1 in this process remain to be
determined. During T-tubule biogenesis and maintenance,
additional membrane may be acquired through fusion of
endocytic vesicles (similar to the process proposed for Schwann
cells in peripheral nerves); defective endocytosis and recycling may
therefore contribute to the phenotype observed in patient muscle.
Tissue-Specific Function
Whilst MTM1 and MTMR2 have very similar sequences (90%
identity) and ubiquitous expression, mutations induce two different
diseases, highlighting that myotubularin functions are not redun-
dant, and isoforms may perform tissue-specific functions. The
membrane remodeling pathway may have different functions in
different tissues, and mutations may affect different protein
functions. Unlike the myotubularin family, for dynamin 2 the same
gene is mutated in two tissue-specific disorders. The tissue-specific
function may thus be dictated by the ability of dynamins to promote
membrane fission or not. Inhibition or slow GTPase hydrolysis
would favormembranetubules, and fastGTP hydrolysiswould lead
to fission and vesicle formation. Inhibition of membrane fission will
lead to the neurological and neuropathyphenotypes while increased
fission may prevent formation of T-tubules and lead to muscle
contraction defects. Supporting this theory DNM2 mutations
causing CNM have been shown to have increased oligomer stability
and GTPase activity [86,87]. However in contrast to BIN1, DNM2
was not observed at T-tubules to date. Regulation of this balance
can be due to tissue-specific isoforms, interactors, or post-
translational regulation as most of these proteins are ubiquitous.
Conclusions and Pending Issues
Animal models were instrumental to decipher the cellular and
physiological functions of the implicated proteins and will be an
asset to further characterize the underlying pathological mecha-
nisms and test therapeutic approaches. Myotubularins, amphi-
physins, and dynamins play a key role in membrane remodeling.
Mammalian models could now be used to follow the dynamics of
membrane remodeling and trafficking in the affected tissues and to
characterize the tissue-specific regulation of the membrane fission
process. Phosphoinositides associated with these proteins are
involved in membrane trafficking; however, the molecular link
between phosphoinositides and membrane remodeling and how
this relates to T-tubule formation and myelin maintenance remain
to be deciphered.
A glossary and useful links can be found in Text S1.
Supporting Information
Protocol S1 Supplementary bioinformatics methods.
(DOC)
Figure 3. Cellular functions of myotubularins, amphiphysins, and dynamins implicated in human diseases and their related
pathological mechanisms. (A) Human diseases, (B) their related pathological mechanisms. Membrane fission is necessary for vesicle formation and
subsequent trafficking, while inhibition of membrane fission or membrane addition at the T-tubules in muscle may be necessary for their formation
and maintenance.
doi:10.1371/journal.pgen.1002595.g003
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dynamin families and linked human diseases.
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Text S1 Glossary and useful links.
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